Cargando…
Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701060/ https://www.ncbi.nlm.nih.gov/pubmed/33180232 http://dx.doi.org/10.1007/s11523-020-00772-4 |
| _version_ | 1783616413933502464 |
|---|---|
| author | Niederwieser, Dietger Hamm, Caroline Cobb, Patrick Mo, Mindy Forsyth, Cecily Tucci, Alessandra Hanes, Vladimir Delwail, Vincent Hajek, Roman Chien, David |
| author_facet | Niederwieser, Dietger Hamm, Caroline Cobb, Patrick Mo, Mindy Forsyth, Cecily Tucci, Alessandra Hanes, Vladimir Delwail, Vincent Hajek, Roman Chien, David |
| author_sort | Niederwieser, Dietger |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7701060 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77010602020-12-03 Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product Niederwieser, Dietger Hamm, Caroline Cobb, Patrick Mo, Mindy Forsyth, Cecily Tucci, Alessandra Hanes, Vladimir Delwail, Vincent Hajek, Roman Chien, David Target Oncol Correction Springer International Publishing 2020-11-12 2020 /pmc/articles/PMC7701060/ /pubmed/33180232 http://dx.doi.org/10.1007/s11523-020-00772-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
| spellingShingle | Correction Niederwieser, Dietger Hamm, Caroline Cobb, Patrick Mo, Mindy Forsyth, Cecily Tucci, Alessandra Hanes, Vladimir Delwail, Vincent Hajek, Roman Chien, David Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product |
| title | Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product |
| title_full | Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product |
| title_fullStr | Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product |
| title_full_unstemmed | Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product |
| title_short | Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product |
| title_sort | correction to: efficacy and safety of abp 798: results from the jasmine trial in patients with follicular lymphoma in comparison with rituximab reference product |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701060/ https://www.ncbi.nlm.nih.gov/pubmed/33180232 http://dx.doi.org/10.1007/s11523-020-00772-4 |
| work_keys_str_mv | AT niederwieserdietger correctiontoefficacyandsafetyofabp798resultsfromthejasminetrialinpatientswithfollicularlymphomaincomparisonwithrituximabreferenceproduct AT hammcaroline correctiontoefficacyandsafetyofabp798resultsfromthejasminetrialinpatientswithfollicularlymphomaincomparisonwithrituximabreferenceproduct AT cobbpatrick correctiontoefficacyandsafetyofabp798resultsfromthejasminetrialinpatientswithfollicularlymphomaincomparisonwithrituximabreferenceproduct AT momindy correctiontoefficacyandsafetyofabp798resultsfromthejasminetrialinpatientswithfollicularlymphomaincomparisonwithrituximabreferenceproduct AT forsythcecily correctiontoefficacyandsafetyofabp798resultsfromthejasminetrialinpatientswithfollicularlymphomaincomparisonwithrituximabreferenceproduct AT tuccialessandra correctiontoefficacyandsafetyofabp798resultsfromthejasminetrialinpatientswithfollicularlymphomaincomparisonwithrituximabreferenceproduct AT hanesvladimir correctiontoefficacyandsafetyofabp798resultsfromthejasminetrialinpatientswithfollicularlymphomaincomparisonwithrituximabreferenceproduct AT delwailvincent correctiontoefficacyandsafetyofabp798resultsfromthejasminetrialinpatientswithfollicularlymphomaincomparisonwithrituximabreferenceproduct AT hajekroman correctiontoefficacyandsafetyofabp798resultsfromthejasminetrialinpatientswithfollicularlymphomaincomparisonwithrituximabreferenceproduct AT chiendavid correctiontoefficacyandsafetyofabp798resultsfromthejasminetrialinpatientswithfollicularlymphomaincomparisonwithrituximabreferenceproduct |